Skip to content
Priorities for developing respiratory syncytial virus (RSV) vaccines in different target populations

Global interactive maps of clinical trials of candidate RSV vaccines, monoclonals and antivirals

Drysdale S.B, Barr R.S, Rollier C.S, Green A.C, Pollard A.J, Sande C.J. Science Translational Medicine.

Vol. 12, Issue 535, eaax2466. 18 March 2020

Clinical trial phase

Status of clinical trial (December 2019)

Interventions tested

Copyright © 2021 Priorities for developing respiratory syncytial virus (RSV) vaccines in different target populations